This site uses cookies in order to regularly improve the operation of the site. You declare that you agree herewith by using this website. Further information



All plants for our preparations grow in Switzerland, Germany and France. For their harvest and further processing, we focus on the highest pharmaceutical quality and sustainability.

Our production involves a lot of manual work, from harvesting to the selection of the plant parts and the packaging of the ampoules. Additionally, we use complex machines and production lines. All processes are subject to the strongest guidelines of Good Agriculture and Good Manufacturing Practice (GAP/GMP).

Watch the video:

Two substances are said to be most important for the mistletoe’s use in cancer therapy: Viscotoxins and mistletoe lectins. Their concentration in the plant varies according to its subspecies, its host tree and the season, especially in summer and winter. This explains why we harvest mistletoe twice a year, strictly separated by subspecies and host trees, and produce a fermented summer and winter extract each.

Those summer and winter extracts are mixed on a special machine at over 10,000 revelations per minute, resulting in final preparations with a balanced ratio of viscotoxins and mistletoe lectins.

You are leaving the website of Iscador AG

You are leaving the website of Iscador AG and are going to the website of another provider. The contents published there as well as their designs have been created without the assistance of Iscador AG and are subject to the exclusive responsibility of the other provider. Iscador AG shall not assume any liability for the accuracy, completeness and actuality of this information and possible consequences from their use. You accept the aforementioned information by continuing on to the external page.